Analyst Rating: Will Pardes Biosciences Inc (PRDS) Stock Do Better Than the Market?

Wall Street is positive on Pardes Biosciences Inc (PRDS). On average, analysts give PRDS a Buy rating. The average price target is $4.083, which means analysts expect the stock to add by 168.62% over the next twelve months.That average ranking earns PRDS an Analyst Rating of 26, which is better than 26% of stocks based on